Proceedings of the Texas A&M Medical Student Grand Rounds

Functionalization of Artificial Dermis with EGF for the Treatment of Burn Wounds

July 27, 2021 Lorenz Michael Estrella

Lorenz Michael Estrella

Introduction: Burns are a very common form of injury, in the United States alone, 500,000 people seek treatment for burns, with 40,000 of those cases resulting in hospitalization, and 4,000 people dying from their burn injuries every year.1 Burns cause thermal damage to cells leading to necrosis and the formation of an eschar2. Burns result in the mass release of many pro-inflammatory cytokines and other molecules which are critical for wound healing1.3 Epidermal growth factor is a known modulator of the release and actions of these cytokines, as well as a key factor in wound healing.8 By functionalizing a skin graft used to treat burns with EGF, it has the potential Methods: Rats were subject to burns using hot metal and then treated with EGF solutions or creams. Various tissue samples or the burns wounds and surrounding areas were taken to observe healing microscopically.4,5,6,7,8 Expression levels of inflammatory molecules and other mediators of wound healing were also measured.4,5,6,7,8 Results: Mice burn wounds treated with EGF consistently showed improved wound healing measured by levels of inflammatory mediators when compared to no treatment.4,5,7 All studies consistently found a time dependent change in levels of inflammatory mediators such as IL-6 and TGF-a when burn wound were treated with EGF.4,5,7 When treated with EGF, pro-inflammatory factors such as IL-1 and TGF-a tended to increase during the early stages of wound healing and fall below control levels during the later stages ;at corresponds to better healing outcomes.4,5,7,8 Tissue samples taken from the surroundings of the burn wound treated with EGF also displayed less inflammation and decreased apoptosis 6. Conclusions: The effects of EGF are preserved when delivered via skin graft8, so enhance of skin graft therapy for burn wounds by functionalizing the graft with EGF appears to be a viable clinical option. Experiments have shown that EGF is able to increase the rate of

  1. Nielson CB, Duethman NC, Howard JM, Moncure M, Wood JG. Burns: Pathophysiology of Systemic Complications and Current Management. J Burn Care Res. 2017;38(1):e469-e481. doi:10.1097/BCR.0000000000000355
  2. Singer AJ, Boyce ST. Burn Wound Healing and Tissue Engineering. J Burn Care Res. 2017;38(3):e605-e613. doi:10.1097/BCR.0000000000000538
  3. Roshangar L, Soleimani Rad J, Kheirjou R, Reza Ranjkesh M, Ferdowsi Khosroshahi A. Skin Burns: Review of Molecular Mechanisms and Therapeutic Approaches. Wounds. 2019;31(12):308
  4. Guo HF, Mohd Ali R, Abd Hamid R, et al. Epidermal Growth Factor and Tocotrienol-Rich Fraction Cream Formulation Accelerates Burn Healing Process Based on Its Gene Expression Pattern in Deep Partial-Thickness Burn Wound Model [published online ahead of print, 2020 Nov 26]. Int J Low Extrem Wounds. 2020;1534734620971066. doi:10.1177/1534734620971066
  5. Rezaei F, Damoogh S, Reis RL, Kundu SC, Mottaghitalab F, Farokhi M. Dual drug delivery system based on pH-sensitive silk fibroin/alginate nanoparticles entrapped in PNIPAM hydrogel for treating severe infected burn wound. Biofabrication. 2020;13(1):015005. Published 2020 Oct 20. doi:10.1088/1758-5090/abbb82
  6. Kaya O, Orhan E, Sapmaz-Metin M, Topçu-Tarladaçalışır Y, Gündüz Ö, Aydın B. The effects of epidermal growth factor on early burn-wound progression in rats. Dermatol Ther. 2020;33(1):e13196. doi:10.1111/dth.13196
  7. Guo HF, Abd Hamid R, Mohd Ali R, et al. Healing Properties of Epidermal Growth Factor and Tocotrienol-Rich Fraction in Deep Partial-Thickness Experimental Burn Wounds. Antioxidants (Basel). 2020;9(2):130. Published 2020 Feb 3. doi:10.3390/antiox9020130
  8. Yoon D, Yoon D, Cha HJ, Lee JS, Chun W. Enhancement of wound healing efficiency mediated by artificial dermis functionalized with EGF or NRG1. Biomed Mater. 2018;13(4):045007. Published 2018 Apr 17. doi:10.1088/1748-605X/aaac37

 

 

 

Inflammation Wound Healing
Previous Post

SOX2 as a Target for Tumor Regression and Preventing Metastasis in Squamous Cell Lung Cancer

Next Post

Targeting the Crosstalk Between M2 Macrophages and Mesenchymal Stem Cells for the Treatment of Osteoporosis: The Role of TGF-β and miRNA Mechanisms via Release of Extracellular Vesicles (Exosomes)

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.